Tumor cells exhibiting high SIGLEC15 expression demonstrated reduced epithelial–mesenchymal transition (EMT) tendencies compared to those with lower expression levels, potentially through the regulation of ZEB1 expression. This evidence concerns the gene ZEB1 and neoplasm.